5-HT3 receptor antagonists in neurologic and neuropsychiatric disorders: The iceberg still lies beneath the surface - Fakhfouri, G; Rahimian, R; Dyhrfjeld-Johnsen, J (Pharmacol Rev, 2019)
et al.